1. Home
  2. CTMX vs IDN Comparison

CTMX vs IDN Comparison

Compare CTMX & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.29

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Logo Intellicheck Inc.

IDN

Intellicheck Inc.

HOLD

Current Price

$6.42

Market Cap

101.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTMX
IDN
Founded
2008
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
596.2M
101.6M
IPO Year
2015
1999

Fundamental Metrics

Financial Performance
Metric
CTMX
IDN
Price
$4.29
$6.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$6.50
$7.33
AVG Volume (30 Days)
2.8M
133.6K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
50.22
N/A
EPS
0.24
0.01
Revenue
$113,631,000.00
$21,968,000.00
Revenue This Year
N/A
$12.25
Revenue Next Year
N/A
$12.39
P/E Ratio
$18.32
$684.90
Revenue Growth
N/A
14.20
52 Week Low
$0.40
$2.17
52 Week High
$4.62
$7.48

Technical Indicators

Market Signals
Indicator
CTMX
IDN
Relative Strength Index (RSI) 57.67 51.06
Support Level $3.86 $6.51
Resistance Level $4.48 $7.14
Average True Range (ATR) 0.25 0.36
MACD 0.02 -0.07
Stochastic Oscillator 73.57 30.14

Price Performance

Historical Comparison
CTMX
IDN

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

Share on Social Networks: